EQT Private Equity, via the EQT IX fund, is to acquire SPT Labtech, a manufacturer and designer of automated instruments and consumables for life science research, in a deal worth £650 million.
Together with management, EQT Private Equity will support and accelerate SPT Labtech’s future growth.
Based in Melbourn, UK, SPT Labtech is a manufacturer and designer of automated liquid handling, sample preparation, and storage instruments, as well as corresponding consumables and support services for life science research. The Company was founded in 1997 and spun out from TTP Group. Since 2018 it has been owned by Battery Ventures.
Following this transaction, EQT IX is expected to be 85-90% invested – including closed and/or signed investments, announced public offers, if applicable, and less any expected syndication.
